Autopsy report · NCT00610792
Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens
Cause of deathRegulatory or ethics
“Study never submitted to IND. Study is being sponsored by Johnson and Johnson in the EU only.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Sponsor type
- Industry
- Conditions
- Ovarian Cancer
- Interventions
- bortezomib; pegylated liposomal doxorubicin
- Participants
- 91 (planned, not actual)
- Sites
- 7
- Countries
- Italy, Switzerland
Trials that died the same way
- A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression
“Study did not receive funding and was never carried out.” - Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
“Study was never initiated due to company decision. No study subjects were ever enrolled or treated.” - An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris
“Study was never initiated due to company decision. No study subjects were ever enrolled or dosed.” - Computer-Based Program to Facilitate Readiness and Motivation for Smoking Cessation
“Due to staff changes the study never started.” - Supervisory Neglect, Non-Accidental Trauma, Brief Intervention, and Treatment Referral
“Study was never initiated. No IRB approval obtained, and no participants enrolled.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.